C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
JUSHF US MSO

Jushi Holdings

OTCMKTS · JUSHF

Multi-state cannabis operator focused on the eastern US with branded retail and cultivation.

$0.42
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
52/100 composite
Fundamentals66
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

Jushi Holdings earns a Neutral rating, with a 52.1 composite score and low 1/5 conviction. Fundamentals provide the strongest contribution at 66, supported by comparatively robust gross and operating margin subscores, positive EBITDA, and modest year-over-year revenue growth. Regulatory ranks second at 58, reflecting a favorable jurisdiction and no enforcement hits, offset by weak filing cadence. Market contributes only 40 because no quote was available from institutional pricing feeds, limiting price-based confirmation. Editorial contributes 30, with no qualifying newsroom or brief activity in CIN newsroom coverage. The resulting profile supports the middle band rather than an Overweight stance, as operating progress remains counterbalanced by stretched financial condition, limited market visibility, and sparse editorial momentum.

Licensed fundamentals data show revenue expanding approximately 4.1% year over year, a positive but moderate pace. Gross margin approaches 44.5%, while operating margin stands near 2.4%, explaining the fundamentals pillar’s leadership and strong margin subscores. EBITDA of roughly $39.2 million demonstrates positive operating cash-earnings capacity, but the approximately $71.4 million net loss keeps the financial condition stretched and prevents positive EBITDA from establishing balance-sheet strength. The approximately $89.3 million market capitalization also produces a weaker scale subscore. Primary regulatory filings show the latest filing dated June 24, 2026. No regulatory events appeared during the latest 90-day window, one appeared across 180 days, and no enforcement hits were recorded; however, the low cadence subscore constrains the otherwise favorable regulatory contribution.

The clearest rerating catalyst sits within fundamentals, the strongest pillar. Faster revenue growth combined with sustained gross margin and improved operating margin would deepen the earnings base, while stronger conversion from positive EBITDA toward reduced net losses would directly address the stretched condition. Better filing cadence and renewed pricing availability could raise confidence, but neither carries the same weight as durable earnings conversion. The single most important signal to watch is whether positive EBITDA begins translating into a materially smaller net loss while operating margin expands.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
301 YAMATO ROAD, SUITE 3250, BOCA RATON, FL, 33431
Phone
5616179100
CEO
Jim Cacioppo
CFO
Michelle Mosier
SEC CIK
1909747
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$89.3M
Enterprise value
$351.5M
Price to book
0.69
Price to sales
0.34
EV / EBITDA
9.80
Revenue (TTM)
$265.5M
Gross profit (TTM)
$118.1M
EBITDA
$39.2M
Operating margin
2.4%
Profit margin
-26.9%
Rev growth YoY
4.1%
Return on equity
-3188.3%
Return on assets
1.2%
EPS (TTM)
$-0.36
EPS est. current year
$-0.22
Wall St. target price
$1.50
Shares outstanding
199.7M
Insider ownership
18.4%
Institutional ownership
11.1%
Beta
0.86
Full-time employees
1,288
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Jushi Holdings (JUSHF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Jushi Holdings (JUSHF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (2 bullish signals, 3 bearish signals.)

Bullish and bearish analyst opinions for Jushi Holdings Inc. (JUSHF)

Bullish view. Jushi Holdings Inc. is levered to Virginia and Pennsylvania adult-use conversion; the biggest East Coast catalyst set inside Tier-3 MSOs.

Bearish view. Bears cite balance-sheet stress, dependence on legislative outcomes, and thin free-cash-flow visibility.

Live ratings, price targets, and consensus figures for Jushi Holdings Inc. appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Multi-state cannabis operator focused on the eastern US with branded retail and cultivation.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for JUSHF are maintained by Cannabis Investor News and refreshed throughout the trading day.